We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$667B
AUM Growth
-$78.5B
Cap. Flow
-$15B
Cap. Flow %
-2.25%
Top 10 Hldgs %
32.39%
Holding
14,586
New
1,953
Increased
4,555
Reduced
6,197
Closed
1,571

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.13B
2
T icon
AT&T
T
+$275M
3
AAPL icon
Apple
AAPL
+$248M
4
DIS icon
Walt Disney
DIS
+$235M
5
NKE icon
Nike
NKE
+$195M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.82%
2 Technology 1.6%
3 Consumer Discretionary 1.3%
4 Financials 0.99%
5 Communication Services 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCEL
12101
PUT
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$99K ﹤0.01%
32,800
-6,600
-17% -$30.8K
FRBK
12102
DELISTED
Republic First Bancorp Inc
FRBK
$99K ﹤0.01%
+26,581
New +$89.3K
APTO
12103
DELISTED
Aptose Biosciences, Inc.
APTO
$99K ﹤0.01%
162
-42
-21% -$39.5K
IHTA
12104
DELISTED
Invesco High Income 2024 Target Term Fund
IHTA
$99K ﹤0.01%
+10,028
New +$99K
APRE icon
12105
PUT
Aprea Therapeutics
APRE
$10.5M
$98K ﹤0.01%
1,710
-4,965
-74% -$439K
AVIR icon
12106
Atea Pharmaceuticals
AVIR
$430M
$98K ﹤0.01%
11,012
-67,325
-86% -$1.05M
FOA icon
12107
PUT
Finance of America Companies
FOA
$168M
$98K ﹤0.01%
2,460
-6,130
-71% -$291K
IHD
12108
Voya Emerging Markets High Income Dividend Equity Fund
IHD
$136M
$98K ﹤0.01%
+13,814
New +$101K
USDP
12109
DELISTED
USD PARTNERS LP
USDP
$98K ﹤0.01%
+18,438
New +$108K
BNED icon
12110
PUT
Barnes & Noble Education
BNED
$422M
$97K ﹤0.01%
142
-27
-16% -$24.8K
JQC icon
12111
Nuveen Credit Strategies Income Fund
JQC
$702M
$97K ﹤0.01%
14,996
-25,382
-63% -$165K
SUPV
12112
CALL
Grupo Supervielle
SUPV
$720M
$97K ﹤0.01%
49,800
-42,700
-46% -$91.4K
KRBP
12113
CALL
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$97K ﹤0.01%
2,103
-3,050
-59% -$208K
OPTN
12114
PUT
DELISTED
OptiNose
OPTN
$96K ﹤0.01%
+3,953
New +$132K
TALK
12115
DELISTED
Talkspace
TALK
$96K ﹤0.01%
48,875
+2,596
+6% +$7.43K
ORKA
12116
PUT
Oruka Therapeutics
ORKA
$6.14B
$96K ﹤0.01%
3,725
-2,367
-39% -$71.3K
VBIV
12117
CALL
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$96K ﹤0.01%
1,373
-14,307
-91% -$1.21M
TMDI
12118
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$96K ﹤0.01%
+153,484
New +$173K
NHTC icon
12119
CALL
Natural Health Trends
NHTC
$13.7M
$95K ﹤0.01%
14,100
+3,300
+31% +$23.6K
SCPX
12120
DELISTED
Scorpius Holdings, Inc.
SCPX
$95K ﹤0.01%
8
-15
-65% -$288K
SRXH
12121
SRX Global
SRXH
$35.1M
$94K ﹤0.01%
15
+6
+67% +$43.1K
CTMX icon
12122
PUT
CytomX Therapeutics
CTMX
$715M
$94K ﹤0.01%
21,700
-9,900
-31% -$58K
CTOS icon
12123
PUT
Custom Truck One Source
CTOS
$2.08B
$94K ﹤0.01%
+11,700
New +$101K
ETON icon
12124
PUT
Eton Pharmaceutcials
ETON
$1.71B
$94K ﹤0.01%
22,000
-10,700
-33% -$51.2K
HTOO icon
12125
PUT
Fusion Fuel Green
HTOO
$14.2M
$94K ﹤0.01%
+326
New +$128K

Similar funds

Jeff Yass's Q4 2021 Portfolio in Review

As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
  • Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
  • Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
  • Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
  • Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
  • Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
  • Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.